$218.3M
sold in all offerings
AdvanCell, Inc. is a corporation based in Cambridge, MA in the Biotechnology industry group. From July 16, 2026 to July 16, 2026 it filed 1 private fundraising filing for 1 offering and reported $218 million sold in all.
Updated October 10, 2026 · newest filing Jul 16, 2026
Amount sold
$218.3M
All offerings, newest filing of each
Offered
$315.0M
Total amount sought
Offerings
1
1 filing with amendments
Newest offering
$218.3M
Sold, first filed Jul 16, 2026
Investors
41
In the newest offering
Min. investment
-
In the newest offering
Facts
- Type
- Corporation
- Place
- Cambridge, MA
- Industry group
- Biotechnology
- Listed
- No
- First filing
- July 16, 2026
- Newest filing
- July 16, 2026
- Exemptions
- 506(b)
Offerings
1 offering, newest first, each at its newest filing
| First filed | Amount sold | Offered | Investors | Min. investment | Exemptions | Securities |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | $218.3M | $315.0M | 41 | - | 506(b) | Equity, Securities on exercise of options |
Filing history
1 filing, newest first. An amendment updates an earlier offering.
| Filed | Kind | Amount sold | Offered | Investors |
|---|---|---|---|---|
| Jul 16, 2026 | New offering | $218.3M | $315.0M | 41 |
Related pages
Questions and answers
How much has AdvanCell, Inc. raised in private offerings?
$218 million sold in 1 private offering reported from Jul 16, 2026 to Jul 16, 2026, counting each offering once at its newest filing.
When did AdvanCell, Inc. last file about a private offering?
July 16, 2026. Its newest offering reported $218 million sold of $315 million offered to 41 investors.
Which exemption does AdvanCell, Inc. use?
506(b). Rule 506(b) does not allow public advertising.
Is AdvanCell, Inc. a listed company?
No ticker is linked to this issuer, so it is private or no longer listed.
These are notices that issuers file about their own private offerings, not verified results. Amounts are as stated in the filing. Official public data from private fundraising filings, updated daily. Amount sold is what the issuer had sold when it filed; the offered amount is the total it wants to raise.